Literature DB >> 18300571

Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience.

Mahmoud Abu-Shakra1, Shlomi Codish, Lior Zeller, Talya Wolak, Shaul Sukenik.   

Abstract

Atherosclerotic disease is common in systemic lupus erythematosus and is the result of multiple pathogenic mechanisms that include traditional risk factors as well as SLE-related factors. Endothelial dysfunction and arterial stiffness contribute significantly to the atherogenic process. Dobutamine stress echocardiogram has not been shown to detect subclinical coronary artery disease; however, the high percentage of left ventricular outflow gradient requires further evaluation and follows-up studies.

Entities:  

Mesh:

Year:  2008        PMID: 18300571

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  3 in total

1.  Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus.

Authors:  Marta Vadacca; Enrico M Zardi; Domenico Margiotta; Amelia Rigon; Fabio Cacciapaglia; Luisa Arcarese; Francesca Buzzulini; Antonio Amoroso; Antonella Afeltra
Journal:  Intern Emerg Med       Date:  2011-11-30       Impact factor: 3.397

2.  Early assessment of subclinical myocardial injury in systemic lupus erythematosus by two-dimensional longitudinal layer speckle tracking imaging.

Authors:  Xiaofang Zhong; Lixin Chen; Guijuan Peng; Yuanyuan Sheng; Xiaohua Liu; Yingqi Zheng; Yuxiang Huang; Jinfeng Xu; Yingying Liu
Journal:  Quant Imaging Med Surg       Date:  2022-05

Review 3.  Management of cardiovascular disease in patients with systemic lupus erythematosus.

Authors:  Paramarjan Piranavan; Andras Perl
Journal:  Expert Opin Pharmacother       Date:  2020-06-08       Impact factor: 3.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.